EUVIMEDEUVIMED entdecken
Crossref

Tongxie Yaofang attenuates ulcerative colitis by modulating gut microbiota and IL-10RA/NF-κB-mediated macrophage polarization

Zhao Shang, Li Zhou, Yue Liu, Xiao Yang, Dengke Yao, Feixiang Zhai, Biyu Liu, Yanglin Chen, Xiaojian Zhu, Dan Liu, Bo Yi

Phytomedicine · 2025-11 · 148 · 157459

DOI: 10.1016/j.phymed.2025.157459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Zhao Shang und 10 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Abdominal Surgery Department, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330029, PR …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Ulcerative, NF-kappa B, Drugs, Chinese Herbal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Jiangxi Province Health Commission, Education Department of Jiangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tongxie Yaofang (TXYF), a traditional Chinese herbal formula, has shown therapeutic potential in gastrointestinal disorders. However, its mechanism in ulcerative colitis (UC) remains unclear. This study provides new insights into immune-microbiota crosstalk as a key mechanism driving the protective effects of TXYF. METHODS: A DSS-induced colitis mouse model was used to evaluate TXYF's efficacy. Gut microbiota was profiled by 16S rRNA sequencing, while transcriptomics and network pharmacology identified core pathways. In vivo and in vitro assays examined immune regulation and epithelial barrier function. A THP-1/Caco-2 co-culture system explored IL-10RA-dependent immune-epithelial crosstalk, and fecal microbiota transplantation (FMT) tested the functional role of microbial remodeling. RESULTS: TXYF alleviated colitis symptoms, improved colon histology, and reduced pro-inflammatory cytokines. It reshaped gut microbiota by enriching SCFA-producing beneficial taxa and suppressing pathogenic bacteria. Transcriptomic analyses identified IL-10RA/NF-κB as a novel regulatory axis, and TXYF enhanced IL-10RA expression, inhibited NF-κB activation, and promoted M2 macrophage polarization. The co-culture model revealed IL-10RA-dependent macrophage-epithelial signaling that strengthened tight junction integrity. Importantly, FMT from TXYF-treated donors yielded these therapeutic benefits, reinforcing the evidence for microbiota-driven causality. CONCLUSION: This study is the first to identify IL-10RA/NF-κB as a key immunoregulatory pathway of TXYF, uncover IL-10RA-dependent immune-epithelial communication, and validate gut microbiota as a functional mediator through FMT. Collectively, these findings demonstrate the innovative potential of TXYF as a multi-target herbal therapy for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitis, UlcerativeNF-kappa BDrugs, Chinese HerbalMacrophagesInterleukin-10 Receptor alpha SubunitAnimalsHumansMiceMice, Inbred C57BLCaco-2 CellsFecal Microbiota TransplantationMaleDisease Models, AnimalDextran SulfateCoculture Techniques

Stichwörter der Autor:innen

Gut microbiotaIL-10RAMacrophage polarizationNF-κB signalingTongxie YaofangUlcerative colitis

Substanzen

NF-kappa BDrugs, Chinese HerbalInterleukin-10 Receptor alpha SubunitDextran Sulfate

Autor:innen und Institutionen

  • 2nd Abdominal Surgery Department, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330029, PR China; Jiangxi Province Key Laboratory of Drug Target Discovery and Va…
  • Jiangxi Province Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China; Jiangxi Province Colorectal Tumor Center, Jiangxi Can…
  • Jiangxi Province Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China.
  • The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China.
  • 2nd Abdominal Surgery Department, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330029, PR China; Jiangxi Province Colorectal Tumor Center, Jiangxi Cancer Hospit…
  • Jiangxi Province Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang 330006, PR China. Electronic address: liudan1201jx@ncu.edu.cn.

Förderung

  • Jiangxi Province Health Commission
  • Education Department of Jiangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Shang, Z., Zhou, L., Liu, Y., Yang, X., Yao, D., Zhai, F., Liu, B., Chen, Y., Zhu, X., Liu, D., & Yi, B. (2025). Tongxie Yaofang attenuates ulcerative colitis by modulating gut microbiota and IL-10RA/NF-κB-mediated macrophage polarization. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157459

Vancouver

Shang Z, Zhou L, Liu Y, Yang X, Yao D, Zhai F, et al. Tongxie Yaofang attenuates ulcerative colitis by modulating gut microbiota and IL-10RA/NF-κB-mediated macrophage polarization. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157459

BibTeX
@article{Shang2025,
  author = {Shang, Zhao and Zhou, Li and Liu, Yue and Yang, Xiao and Yao, Dengke and Zhai, Feixiang and Liu, Biyu and Chen, Yanglin and Zhu, Xiaojian and Liu, Dan and Yi, Bo},
  title = {Tongxie Yaofang attenuates ulcerative colitis by modulating gut microbiota and IL-10RA/NF-κB-mediated macrophage polarization},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157459}
}
Kostenlos starten →